{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:49:51Z","timestamp":1783550991583,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.contraception.2008.10.010","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T12:14:43Z","timestamp":1229516083000},"page":"282-289","source":"Crossref","is-referenced-by-count":36,"title":["Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol\/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol\/2 mg cyproterone acetate"],"prefix":"10.1016","volume":"79","author":[{"given":"Ernesta","family":"Palombo-Kinne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilka","family":"Schellschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gr\u00e4ser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.contraception.2008.10.010_bib1","first-page":"3","article-title":"Overview of acne and its treatment","volume":"81","author":"Thiboutot","year":"2008","journal-title":"Cutis"},{"key":"10.1016\/j.contraception.2008.10.010_bib2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archderm.135.9.1101","article-title":"Acne vulgaris. State of the science","volume":"135","author":"Webster","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.contraception.2008.10.010_bib3","first-page":"59","article-title":"Androgen physiology and the cutaneous pilosebaceous unit","volume":"3","author":"Mercurio","year":"2000","journal-title":"J Gend Specif Med"},{"key":"10.1016\/j.contraception.2008.10.010_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000017849","article-title":"Oral contraceptives and cyproterone acetate in female acne treatment","volume":"196","author":"Beylot","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.contraception.2008.10.010_bib5","first-page":"1","article-title":"Oral contraceptives in the treatment of acne","volume":"6","author":"Tan","year":"2001","journal-title":"Skin Therapy Lett"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2008.10.010_bib6","first-page":"8","article-title":"Pharmacology of hormonal contraceptives and acne","volume":"81","author":"O\u2019Connell","year":"2008","journal-title":"Cutis"},{"key":"10.1016\/j.contraception.2008.10.010_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejogrb.2003.09.030","article-title":"Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception","volume":"112","author":"Schindler","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2008.10.010_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestogens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2008.10.010_bib9","first-page":"517","article-title":"A 19-norprogestin without 17\u03b1-ethinyl group II: dienogest from a pharmacodynamic point of view","volume":"31","author":"Oettel","year":"1995","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.contraception.2008.10.010_bib10","series-title":"Dienogest. A clinical study update on dienogest-containing products","first-page":"3","article-title":"The preclinical and clinical profile of dienogest: a short overview","volume":"35(Suppl C)","author":"Oettel","year":"1999"},{"key":"10.1016\/j.contraception.2008.10.010_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0190-9622(08)80076-X","article-title":"Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24\u201325, 1990","volume":"24","author":"Pochi","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.contraception.2008.10.010_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2133.2004.05696.x","article-title":"Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme","volume":"150","author":"Barbier","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.contraception.2008.10.010_bib13","unstructured":"EMEA\/CPMP\/EWP\/2158\/99: Concept paper on the development of a Committee for Proprietary Medicinal Products (CPMP): points to consider on biostatistical\/methodological issues arising from recent CPMP discussions on licensing applications: choice of delta. London, 1999."},{"key":"10.1016\/j.contraception.2008.10.010_bib14","unstructured":"EMEA\/CPMP\/EWP\/2158\/99: Committee for Proprietary Medicinal Products (CPMP): guideline on the choice of the non-inferiority margin. London, 27 July 2005."},{"key":"10.1016\/j.contraception.2008.10.010_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1742-1241.2000.tb11855.x","article-title":"The effects of Valette\u00ae on skin and hair: a post-marketing surveillance study","volume":"54","author":"Zimmermann","year":"2000","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.contraception.2008.10.010_bib16","series-title":"Dienogest. A clinical study update on dienogest-containing products","first-page":"69","article-title":"Antiandrogenic properties of the dienogest-containing oral contraceptive Valette\u00ae","volume":"35(Suppl C)","author":"Moore","year":"1999"},{"key":"10.1016\/j.contraception.2008.10.010_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.contraception.2005.07.010","article-title":"Treating acne with oral contraceptives: use of lower doses","volume":"73","author":"Huber","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.10.010_bib18","series-title":"Dienogest. Pr\u00e4klinik und Klinik eines Gestagens","first-page":"191","article-title":"Beeinflussung klinisch-chemischer und h\u00e4matologischer Parameter nach Verabreichung von MP 2000 \u00fcber 6 Zyklen an gesunden Probandinnen im Rahmen einer Pilot-Studie","author":"Golbs","year":"1995"},{"key":"10.1016\/j.contraception.2008.10.010_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0010-7824(01)00310-9","article-title":"Effect of dienogest-containing oral contraceptives on lipid metabolism","volume":"65","author":"Wiegratz","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2008.10.010_bib20","series-title":"Dienogest. A clinical study update on dienogest-containing products","first-page":"53","article-title":"Clinical findings with the dienogest-containing oral contraceptive Valette\u00ae","volume":"35 (Suppl C)","author":"Moore","year":"1999"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408004915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408004915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:42:16Z","timestamp":1684802536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782408004915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0010782408004915"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2008.10.010","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}